Lynne Elmore joined MUSC Hollings Cancer Center as the director of research development.
Emma Lee Wen knows exactly what science can accomplish.
Lynne Elmore named director of research development at MUSC Hollings Cancer Center
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
The definition of “therapeutic imperative” is this: A treatment necessity that must be met in order to prevent death. Once the imperative is clearly defined, addressing it properly links correct diagnosis with therapy and favorable prognosis. On the other hand, misdiagnosis or inadequate diagnosis fails to provide a framework for highly effective or curative therapy.
This year, Fred Hutch Cancer Center celebrates its 50th anniversary. Fred Hutch will be marking this milestone with a series of historical articles, a timeline, photo archives, and more as the year progresses.
The University of New England recently signed its first intellectual property license agreement with Satya Diagnostics—a company that recently received $100,000 in MaineHealth Bonfire Funding to help it achieve its goal of improving cancer detection and treatment in communities across the world.
Patrizia Cavazzoni will rejoin Pfizer Inc. as chief medical officer and executive vice president.
Jenny Chang, a cancer clinician-scientist, was named executive vice president, president and CEO, and chief academic officer of the Houston Methodist Academic Institute.
